EUVIMEDEUVIMED entdecken
Crossref

Genome‐wide Association Studies Categorized by Class of Antihypertensive Drugs Reveal Complex Pathogenesis of Hypertension with Drug Resistance

Keiko Yamazaki iD, Chikashi Terao iD, Atsushi Takahashi iD, Yoichiro Kamatani iD, Koichi Matsuda iD, Satoshi Asai, Yasuo Takahashi iD

Clinical Pharmacology & Therapeutics · 2023

DOI: 10.1002/cpt.2934 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Pharmacology & Therapeutics, 2023. Verfasst von Keiko Yamazaki und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Genomic Epidemiology and Clinical Trials, Clinical Trials Research Center, Nihon University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Antihypertensive Agents, Hypertension. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Resistant hypertension is defined as uncontrolled blood pressure (BP) despite the use of three or more antihypertensive drugs of different classes. Although genetic factors may greatly contribute to hypertension with resistance to multiple drug classes, more than for general hypertension, its pathogenesis remains unknown. To reveal the genetic background of resistant hypertension, we categorized 32,239 patients whose data were obtained from the BioBank Japan Project, by prescription of 7 classes of antihypertensive drugs and performed genome‐wide association studies (GWAS). Our GWAS identified four loci with significant association ( P < 5 × 10 −8 ): rs6445583 in CACNA1D and rs12308051 in the intergenic region on chromosome 12 for angiotensin II receptor blockers, rs35497065 in FOXA3 for calcium channel blockers, and rs11066280 in HECTD4 for αβ‐blockers. Because these loci are known to be susceptibility loci for hypertension and/or BP, our results indicate that resistant hypertension is caused by a combination of excessive BP and drug resistance to each antihypertensive pharmacological class. Furthermore, to investigate the genetic difference between BP traits and the treatment effectiveness of antihypertensive drugs, we performed gene‐set analysis and calculated the genetic correlation continuously. Most of the genetic factors were in common between BP traits and antihypertensive effectiveness, but it seems that the genetic architecture of the drug response to antihypertensive treatment is more complicated than BP traits. This corresponds to the well‐known mosaic theory of hypertension. Our findings reveal the complex pathogenesis of hypertension with resistance to multiple classes of antihypertensive drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antihypertensive AgentsHypertensionHumansGenome-Wide Association StudyCalcium Channel BlockersBlood PressureDrug Resistance

Substanzen

Antihypertensive AgentsCalcium Channel Blockers

Autor:innen und Institutionen

  • Division of Genomic Epidemiology and Clinical Trials, Clinical Trials Research Center, Nihon University School of Medicine, Tokyo, Japan.
  • Department of Public Health, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Laboratory for Autoimmune Diseases, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Laboratory for Statistical Analysis, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Department of Genomic Medicine, Research Institute, National Cerebral and Cardiovascular Center, Osaka, Japan.
  • Laboratory of Complex Trait Genomics, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan.

ORCID-Profile: Keiko Yamazaki, Chikashi Terao, Atsushi Takahashi, Yoichiro Kamatani, Koichi Matsuda, Yasuo Takahashi

Zitieren

APA

Yamazaki, K., Terao, C., Takahashi, A., Kamatani, Y., Matsuda, K., Asai, S., & Takahashi, Y. (2023). Genome‐wide Association Studies Categorized by Class of Antihypertensive Drugs Reveal Complex Pathogenesis of Hypertension with Drug Resistance. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.2934

Vancouver

Yamazaki K, Terao C, Takahashi A, Kamatani Y, Matsuda K, Asai S, et al. Genome‐wide Association Studies Categorized by Class of Antihypertensive Drugs Reveal Complex Pathogenesis of Hypertension with Drug Resistance. Clinical Pharmacology & Therapeutics. 2023. doi:10.1002/cpt.2934

BibTeX
@article{Yamazaki2023,
  author = {Yamazaki, Keiko and Terao, Chikashi and Takahashi, Atsushi and Kamatani, Yoichiro and Matsuda, Koichi and Asai, Satoshi and Takahashi, Yasuo},
  title = {Genome‐wide Association Studies Categorized by Class of Antihypertensive Drugs Reveal Complex Pathogenesis of Hypertension with Drug Resistance},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2023},
  doi = {10.1002/cpt.2934}
}
Kostenlos starten →